JDJie Dang

Jie Dang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jie Dang has a total of 19 co-authors. Here are the top co-authors by number of shared publications:

  • Jue Zhang

    Academy for Advanced Interdisciplinary Studies, Peking University

    4 shared publications
  • Feihong Dong

    College of Future Technology, State Key Laboratory of Membrane Biology, Peking-Tsinghua Center for Life Sciences, and Institute of Molecular Medicine, Peking University, Beijing, China

    3 shared publications
  • Zhengxin Liu

    Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China

    3 shared publications
  • Jiabin Zhang

    State Key Laboratory of Membrane Biology, National Biomedical Imaging Center, Peking-Tsinghua Center for Life Sciences, Institute of Molecular Medicine, College of Future Technology, Peking University, Beijing 100871, China

    2 shared publications
  • Kaile Wang

    Academy for Advanced Interdisciplinary Studies, Peking University, Beijing 100871, People’s Republic of China

    2 shared publications
  • Diange Zhou

    Arthritis Clinic & Research Center, Peking University People’s Hospital, Beijing 100044, People’s Republic of China

    1 shared publication

Latest Publications

  • Ultrasound-Mediated Antitumor Therapy via Targeted Acoustic Release Carrier of Carbon Monoxide (TARC-CO)

    by Wenyu Guo, Shuo Huang, Jian An, Jiabin Zhang, Feihong Dong, Jie Dang, Jue Zhang

    As one of the most valuable endogenous gas signaling molecules, carbon monoxide (CO) has been demonstrated in numerous studies to show excellent promise in the treatment of diseases, such as cancer. However, for many years, the inherent high affinity of CO for hemoglobin severely impeded the clinical transformation of CO-based treatments. Therefore, the controlled delivery of CO to target tissues has become a common challenge. Herein, an efficient ultrasonic-triggered and targeted CO release strategy was constructed based on a novel targeted acoustic release carrier of carbon monoxide (TARC-CO) that we synthesized in this study. The designed TARC-COs could afford a safe, stable, and ultrasound-guided delivery of CO in vivo by loading a specified dose of CO inside microbubbles, resulting in breast tumor suppression. Taking advantage of the high loading capacity of microbubbles, the unit volume of TARC-CO suspension could encapsulate up to 337.1 ± 8.0 (×103 ppm) of CO. In addition, the satisfactory ultrasound contrast-enhanced ability of TARC-COs achieved real-time interactive guidance and visual policing of CO delivery. For the in vitro antitumor study, TARC-COs with ultrasonic irradiation were demonstrated to effectively induce mitochondrial dysfunction by reducing mitochondrial membrane potential, leading to the apoptosis of 4T1 cells. In addition, we realized that TARC-CO-based treatment could significantly slow the growth rate of tumors by inducing apoptosis, inhibiting the proliferation of cancer cells, and limiting tumor angiogenesis. In summary, this proof-of-concept study demonstrates the feasibility and tremendous potential of TARC-COs for controlled release of CO, which can be expected to provide new inspirations and a promising perspective for therapy based on active gases.


  • Ultrasound-Activated Nanodroplet Disruption of the Enterococcus faecalis Biofilm in Dental Root Canal

    by Jie Dang, Mengqian Zhu, Feihong Dong, Ruoqing Zhong, Zhengxin Liu, Jing Fang, Jue Zhang, Jie Pan

    Conventional methods used to control bacterial biofilm infection in root canals have poor efficacy, causing repeated and chronic infections, which pose a great challenge to clinical treatment. Microbubbles, due to their small size and ultrasound (US)-enhanced cavitation effects, have attracted considerable clinical attention. They possess the potential for therapeutic application in restricted spaces. We address the above problem with a strategy for the restricted space of root canals. Herein, phase-change nanodroplets (P-NDs) exposed to US are combined with common antibacterial drugs to disrupt a 7 day Enterococcus faecalis biofilm in an in vitro human tooth model. Specifically, the preparation of P-NDs is based on secondary cavitation. Their average particle size is similar to 144 nm, and the stability is favorable. The clearance effect for the biofilm is notable (the disruption rate of P-NDs + US is 63.1%, P < 0.01), while the effect of an antibacterial in conjunction with 2% chlorhexidine (Chx) is significant (the antibiofilm rate of P-NDs@2% Chx + US is 96.2%, P < 0.001). Furthermore, biocompatibility testing on human periodontal ligament fibroblasts demonstrated that P-NDs are safe. In summary, the strategy that we have proposed is suitable for the removal of biofilms in root canals. Notably, it also has great potential for application in the treatment of bacterial infections in restricted spaces.


  • Hydrogel Pressure Distribution Sensors Based on an Imaging Strategy and Machine Learning

    by Zhengxin Liu, Tingwei Zhang, Mei Yang, Weizheng Gao, Songjie Wu, Kaile Wang, Feihong Dong, Jie Dang, Diange Zhou, Jue Zhang


  • A Novel Antifungal Plasma-Activated Hydrogel

    by Zhengxin Liu, Yongping Zheng, Jie Dang, Jiabin Zhang, Feihong Dong, Kaile Wang, Jue Zhang

    Antifungal hydrogels with added antifungal drugs have received extensive attention from researchers due to their potential use in various applications, such as wound dressings and ultrasound gel pads. In this study, we proposed and designed an alternative antifungal hydrogel preparation strategy to obtain hydrogels with high antifungal abilities. We employed plasma-activated water (PAW) instead of water in the hydrogel polymerization process to prepare plasma-activated hydrogels (PAH). Disc diffusion assay results revealed that PAH exhibits satisfactory antifungal activity. Interestingly, the oxidation-reduction potential (ORP) of the PAH was significantly lower than that of conventional polyacrylamide (PAAm) hydrogels, and we provided a possible reaction equation to explain the lower value of ORP in the PAH. Furthermore, using electron spin resonance (ESR) spectroscopy, the hydroxyl radical was detected in plasma-activated hydrogels (PAH). Although the active ingredients in the hydrogel cannot be quantitatively measured, the hydroxyl radical and NO3- are speculated to be the main components of PAH with antifungal activity, according to ESR spectroscopy and optical emission spectroscopy. Further experiments also showed that PAH has a longer antifungal lifetime than PAW. In summary, the proposed plasma-activated hydrogels can provide valuable preparation strategies for delivering antifungal capabilities and have many potential applications in biomedical fields.